World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT02309957
Date of registration: 02/12/2014
Prospective Registration: No
Primary sponsor: Kensey Nash Corporation
Public title: EAGLE European Post Market Study EAGLE
Scientific title: Evaluation of an Acellular Osteochondral Graft for Cartilage LEsions ("EAGLE") European Post Market Study
Date of first enrolment: May 2011
Target sample size: 33
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02309957
Study type:  Observational
Study design:   
Phase: 
Countries of recruitment
Germany Italy Netherlands United Kingdom
Contacts
Name:     Justus Gille, PD Dr med
Address: 
Telephone:
Email:
Affiliation:  University of Schleswig-Holstein, Campus Lübeck
Key inclusion & exclusion criteria

Inclusion Criteria:

- Pre-procedure KOOS Pain subscale score less than or equal to 70.

- ICRS grade 3 or 4 focal articular cartilage lesion on the medial femoral condyle,
lateral femoral condyle or trochlea, which measures less than or equal to15mm in
diameter.

- Cartilage lesion is amenable to treatment with a single BioMatrix CRD or an
osteochondral autograft.

Exclusion Criteria:

- Previous cartilage repair procedure (i.e., microfracture, OATS, ACI) at the intended
implantation site.

- Clinically significant (> 5 degrees) varus or valgus malalignment in either knee.

- Osteoarthritis in the injured knee.

- Inflammatory arthropathy

- Osteomyelitis or other active infection in either lower limb.

- Cortisone or hyaluronic acid knee injections in the past 3 months

- Body mass index greater than 35.



Age minimum: 18 Years
Age maximum: N/A
Gender: All
Health Condition(s) or Problem(s) studied
Acute Knee Cartilage Injury
Tear of Articular Cartilage of Knee, Current
Intervention(s)
Device: BioMatrix CRD
Primary Outcome(s)
Rate of Implant Failure [Time Frame: 24 months]
Secondary Outcome(s)
Knee Related Adverse Events [Time Frame: 24 months]
Quality of repair tissue as assessed by magnetic resonance imaging [Time Frame: at 24 months]
Improvement in knee pain and function as reported by patients on the Knee Injury and Osteoarthritis Outcome Score (KOOS) Questionnaire [Time Frame: 24 months]
Secondary ID(s)
EAGLE EU Post Market Study
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history